Kura Oncology says its patient-first culture is a core operating principle, with COO Kathy Ford positioning it as central to execution and identity. The company

Kura Oncology says its patient-first culture is a core operating principle, with COO Kathy Ford positioning it as central to execution and identity. The company also pointed to AML research featured on the cover of Blood as evidence of clinical momentum.